A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4

Clinical trial NCT03844191 · COMPLETED

Trial details

NCT number: NCT03844191
Sponsor: CeleCor Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Coronary Disease

Start date: 2019-02-18
Primary completion: 2019-11-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.